Ocugen, INC. (OCGN) — 10-Q Filings

10-Q Filings (6)

• Ocugen's Losses Widen to $50.1M Amid Soaring R&D Costs — Nov 5, 2025 Risk: high
  Ocugen, Inc. reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $50.1 million, up from $40.2 million in the same
• Ocugen's Q2 Net Loss Widens to $19.5M Amid R&D Push — Aug 4, 2025 Risk: high
  Ocugen, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods. The company's net loss for the three
• Ocugen Files Q1 2025 10-Q Report — May 9, 2025 Risk: medium
  Ocugen, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its business operations. Key fi
• Ocugen Q3 Revenue Surges to $1.01M, R&D Costs Decline — Nov 14, 2024 Risk: medium
  Ocugen, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported revenue of $1.01 million for the third quarter of 2024, a significant
• Ocugen Files 10-Q for Q2 2024 — Aug 8, 2024 Risk: medium
  Ocugen, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and provided updates on its business operations. Key
• Ocugen, Inc. Files 10-Q for Period Ending March 31, 2024 — May 14, 2024 Risk: medium
  Ocugen, Inc. (OCGN) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Ocugen, Inc. filed a 10-Q report for the period ending March 31, 2024. The fil

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX